Hansa Biopharma — Major Shareholding Notification 2018

Oct 5, 2018

Issuer Hansa Biopharma AB

Holder

OppenheimerFunds, Inc

Instrument

Instrument	Ordinary Shares SE0002148817
Before the transaction
Shares	1,865,379
Voting rights	1,865,379
Transaction
Reason for major shareholding notification Buy
Date	01/10/2018
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,960,537
Directly held voting rights	0
Indirectly held voting rights	1,960,537
Percentage
Directly held shares	5.1413 %
Directly held voting rights	0 %
Indirectly held voting rights	5.1413 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	5.1413 %	1,960,537
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	5.1413 %	1,960,537

Chain of controlling companies

	Voting rights % Voting rights Company
1,588,103 4.16463		Oppenheimer Global Opportunities Fund
369,363	0.96861	Oppenheimer International Small-Mid Company Fund
3,071	0.00805	OFIGTC International Small-Mid Cap Fund

Group total holdings

Voting rights 1,960,537 Percentage of voting rights 5.1413

Published

05/10/2018 11:00
Contact
Name	Stephen Volpe
Phone		+1 212 323 4858 Email jgottlieb@ofiglobal.com

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25